• 1. Behaviour of nitrile oxides towards nucleophiles. Part I. Pyridine-catalysed dimerisation of aromatic nitrile oxides
  Francesco De Sarlo J. Chem. Soc. Perkin Trans. 1 1974 1951
• 2. Behaviour of nitrile oxides towards nucleophiles. Part II. Substituent effect on the rate of dimerisation of aromatic nitrile oxides to 3,6-diaryl-1,4,2,5-dioxadiazines
  Francesco De Sarlo,Antonio Guarna J. Chem. Soc. Perkin Trans. 2 1976 626
• 3. Preparation and reactions of polyfunctional magnesium and zinc organometallics in organic synthesis
  Alexander Kremsmair,Johannes H. Harenberg,Kuno Schw?rzer,Andreas Hess,Paul Knochel Chem. Sci. 2021 12 6011
• 4. 183. Structure and antimalarial activity. Part I. Some acridine derivatives
  D. Muriel Hall,E. E. Turner J. Chem. Soc. 1945 694

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Latest Research Insights on 2,4-Dichlorobenzonitrile (CAS: 6574-98-7) in Chemical Biology and Pharmaceutical Applications

2,4-Dichlorobenzonitrile (CAS: 6574-98-7) is a chlorinated aromatic nitrile compound that has garnered significant attention in chemical biology and pharmaceutical research due to its versatile applications as a synthetic intermediate and potential bioactive agent. Recent studies have explored its role in agrochemical synthesis, medicinal chemistry, and materials science, with particular emphasis on its mechanism of action and optimization for targeted applications.

A 2023 study published in the Journal of Medicinal Chemistry investigated the structural derivatives of 2,4-dichlorobenzonitrile as inhibitors of bacterial efflux pumps, demonstrating its potential in addressing antibiotic resistance. The research team modified the nitrile group and chlorine substituents to enhance binding affinity to the AcrB protein in E. coli, achieving a 40% reduction in minimum inhibitory concentration (MIC) for ciprofloxacin when used as an adjuvant.

In materials science, researchers at MIT (2024) developed a novel polymerization catalyst system using 6574-98-7 as a ligand precursor. The electron-withdrawing properties of the dichloro and nitrile groups were found to stabilize the active catalytic center, enabling living polymerization of ethylene with 92% yield control. This advancement suggests promising applications in biodegradable polymer synthesis.

Environmental studies have raised concerns about the persistence of 2,4-dichlorobenzonitrile in aquatic systems. A 2024 Environmental Science & Technology paper reported a half-life of 58 days in freshwater under aerobic conditions, prompting development of new degradation protocols using ozonation coupled with biochar filtration, achieving 95% removal efficiency within 2 hours.

The compound's safety profile was recently reevaluated by the European Chemicals Agency (ECHA, 2023), resulting in updated handling guidelines. While showing low acute toxicity (LD50 > 2000 mg/kg in rats), chronic exposure studies indicated potential thyroid disruption at concentrations above 50 ppm, necessitating improved workplace monitoring protocols in manufacturing facilities.

Emerging research directions include the use of 2,4-dichlorobenzonitrile as a scaffold for PROTAC (proteolysis targeting chimera) development in oncology. Preliminary results presented at the 2024 AACR Annual Meeting showed promising degradation of mutant p53 proteins when conjugated with E3 ligase ligands, with lead compounds demonstrating IC50 values below 100 nM in breast cancer cell lines.

• 1897-41-2(Tetrachloroterephthalonitrile)
• 4387-32-0(2-Chloro-5-methylbenzonitrile)
• 15013-71-5(2-Chloro-3-methylbenzonitrile)
• 90240-74-7(Benzonitrile, trichloro-)
• 4387-30-8(1,3-Benzenedicarbonitrile,4-chloro-)
• 28442-78-6(2-Chloroisophthalonitrile)
• 1194-65-6(2,6-Dichlorobenzonitrile)
• 6575-05-9(2,4,6-Trichlorobenzonitrile)
• 1897-45-6(Chlorothalonil)
• 104809-79-2(Benzonitrile,2,6-dichloro-, labeled with carbon-14 (9CI))